Obicetrapib - ALZFORUM
2023年11月7日 · Obicetrapib additively lowered cholesterol when given with statins and ezetimbe, a drug that blocks intestinal cholesterol absorption (Ballantyne et al., 2023). Even though CETP inhibitors raise HDL, their cardiovascular benefits are now attributed to their ability to lower LDL and apolipoprotein B (see Nelson et al., 2022 ; Mehta et al., 2023 ).
Lipid lowering effects of the CETP inhibitor obicetrapib in
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial. Nat Med. 2022 Aug;28(8):1672-1678. Epub 2022 Aug 11 PubMed. Recommends. Please login to recommend the paper. Comments. No Available Comments. Make a Comment. To make a comment you must login or register.
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin ...
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial. J Clin Lipidol. 2023;17(4):491-503. Epub 2023 Jun 3 PubMed. Recommends. Please login to recommend the paper. Comments. No Available Comments. Make a Comment. To make a comment you must login or register.
This paper appears in the following: - ALZFORUM
Nordestgaard LT, Christoffersen M, Lauridsen BK, Afzal S, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.
Therapeutics Search | ALZFORUM
Find a Therapeutic By Name Go NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-552 ABBV-916 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24.060 ACI-3024 ACI-35 ACI-7104.056 Acitretin ACP-204 ADEL-Y01 Aduhelm AF 102B Affitope AD02 AGB101 AIT-101 AKST4290 AL002 AL003 AL044 AL101 ALIA-1758 …
Therapeutics - ALZFORUM
2015年11月25日 · Find a Therapeutic By Name Go NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-552 ABBV-916 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24.060 ACI-3024 ACI-35 ACI-7104.056 Acitretin ACP-204 ADEL-Y01 Aduhelm AF 102B Affitope AD02 AGB101 AIT-101 AKST4290 AL002 AL003 …
Cholesteryl Ester Transfer Protein Inhibition Reduces Major …
Nelson AJ, Sniderman AD, Ditmarsch M, Dicklin MR, Nicholls SJ, Davidson MH, Kastelein JJ.Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
Therapeutics | ALZFORUM
2015年11月25日 · Find a Therapeutic By Name Go NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-552 ABBV-916 ABBV-CLS-7262 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24.060 ACI-3024 ACI-35 ACI-7104.056 Acitretin ACP-204 ADEL-Y01 Aduhelm AF 102B Affitope AD02 AGB101 AIT-101 AKST4290 AL002 …
Therapeutics Search - ALZFORUM
Obicetrapib : TA-8995 : Alzheimer's Disease (Phase 2) NewAmsterdam Pharma: Cholesterol: Small Molecule: OLX-07010: Alzheimer's Disease (Phase 1) Oligomerix, Inc. Tau: Small Molecule: ORM-12741: Alzheimer's Disease (Phase 2) Orion Pharma: Other Neurotransmitters: Small Molecule: PBT2: PBT-2: Alzheimer's Disease (Inactive), Huntington's Disease ...
Therapeutics Search - ALZFORUM
Obicetrapib : TA-8995 : Alzheimer's Disease (Phase 2) NewAmsterdam Pharma: Cholesterol: Small Molecule: Octagam®10%: Intravenous Immunoglobulin, NewGam: Alzheimer's Disease (Inactive), Mild Cognitive Impairment (Inactive) Octapharma: Amyloid-Related, Inflammation: Immunotherapy (passive) Immunodeficiency disorders: OLX-07010: Alzheimer's ...